Fortschr Neurol Psychiatr 2011; 79(12): 703-710
DOI: 10.1055/s-0031-1281854
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Psychiatrische Nebenwirkungen der Tiefen Hirnstimulation bei idiopathischem Parkinsonsyndrom

Psychiatric Side Effects of Deep Brain Stimulation in Parkinson’s Disease
T. Skuban*
,
J. Flohrer*
,
J. Klosterkötter
,
J. Kuhn
Further Information

Publication History

Publication Date:
09 December 2011 (online)

Zusammenfassung

Mit der Tiefen Hirnstimulation (THS) steht seit den 90er-Jahren des 20. Jahrhunderts ein weiteres effektives Therapieverfahren für die Parkinsonerkrankung zur Verfügung, mit dem weltweit schon über fünfzigtausend Patienten behandelt wurden. Auch wenn die THS eine nebenwirkungsarme Methode ist, gibt es doch relevante unerwünschte Wirkungen, die besonders auch den psychiatrischen Bereich betreffen können. In der vorliegenden Arbeit soll ein umfassender Überblick über die Datenlage zu psychiatrischen Auswirkungen der THS bei Morbus Parkinson gegeben werden. Unter Verwendung einer systematischen Literaturrecherche (Suchzeitraum 1999 bis Februar 2011) wurden alle diesbezüglichen medizinischen Veröffentlichungen berücksichtigt. Dabei wurde offensichtlich, dass die ermittelten Studien hinsichtlich ihrer Methodik und der Ergebnisse höchst inkonsistent sind. Es zeichnet sich allerdings ab, dass postoperativ besondere Aufmerksamkeit einer erhöhten Suizidalität und affektiven Auslenkungen (sowohl zum depressiven als auch zum manischen Pol) gewidmet werden sollte. Hieraus ergibt sich die Empfehlung einer engmaschigen interdisziplinären prä- und postoperativen Evaluation von Parkinsonpatienten, die mittels THS behandelt wurden.

Abstract

Since the 1990 s deep brain stimulation (DBS) has provided an effective tool for the treatment of Parkinson’s disease. About fifty thousand Parkinson patients have been treated by DBS so far. Although a relatively safe intervention, there are still some considerable side effects, psychiatric and non-psychiatric. We conducted a structured search using PubMed and included publications from 1999 to February 2011 to provide an overview of the current data concerning psychiatric side effects of DBS in Parkinson’s disease. There was a tremendous variety and inconsistency concerning methods and results of the studies we included. However, it became apparent that postoperatively increased attention should be paid concerning a potentially increased suicidality and affective alterations (particularly manic states). We suggest frequent pre- and postoperative evaluations of Parkinson patients treated with DBS. 

* Diese Autoren haben in gleicher Weise zum Manuskript beigetragen.


 
  • Literatur

  • 1 Thobois S, Ardouin C, Lhommee E et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson’s disease: predictors and underlying mesolimbic denervation. Brain 2010; 133: 1111-1127
  • 2 Temel Y, Kessels A, Tan S et al. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 2006; 12: 265-272
  • 3 Krauss JK, Volkmann J. Tiefe Hirnstimulation. 1. Aufl. Darmstadt: Steinkopff Verlag; 2004
  • 4 Woods SP, Fields JA, Troster AI. Neuropsychological sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s disease: a critical review. Neuropsychol Rev 2002; 12: 111-126
  • 5 Alegret M, Junque C, Valldeoriola F et al. Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease. Arch Neurol 2001; 58: 1223-1227
  • 6 Temel Y, Visser-Vandewalle V, Aendekerk B et al. Acute and separate modulation of motor and cognitive performance in parkinsonian rats by bilateral stimulation of the subthalamic nucleus. Exp Neurol 2005; 193: 43-52
  • 7 Funkiewiez A, Ardouin C, Caputo E et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2004; 75: 834-839
  • 8 Troster AI, Fields JA, Wilkinson S et al. Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatology. Stereotact Funct Neurosurg 2003; 80: 43-47
  • 9 Tan SK, Temel Y, Blokland A et al. The subthalamic nucleus: From response selection to execution. J Chem Neuroanat 2006; 31: 155-161
  • 10 Smeding HM, Speelman JD, Koning-Haanstra M et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology 2006; 66: 1830-1836
  • 11 Deuschl G, Schade-Brittinger C, Krack P et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 2006; 355: 896-908
  • 12 Pollak P, Benabid AL, Gross C. Effects of the stimulation of the subthalamic nucleus in Parkinson’s disease. Rev Neurol 1993; 149: 175-176
  • 13 Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357-381
  • 14 Berney A, Vingerhoets F, Perrin A et al. Effect on mood of subthalamic DBS for Parkinson’s disease: a consecutive series of 24 patients. Neurology 2002; 59: 1427-1429
  • 15 Schneider F, Habel U, Volkmann J et al. Deep brain stimulation of the subthalamic nucleus enhances emotional processing in Parkinson disease. Arch Gen Psychiatry 2003; 60: 296-302
  • 16 Vernaleken I, Kuhn J, Lenartz D et al. Bithalamical deep brain stimulation in tourette syndrome is associated with reduction in dopaminergic transmission. Biol Psychiatry 2009; 66: e15-e17
  • 17 Voon V, Saint-Cyr J, Lozano AM et al. Psychiatric symptoms in patients with Parkinson disease presenting for deep brain stimulation surgery. J Neurosurg 2005; 103: 246-251
  • 18 Houeto JL, Mallet L, Mesnage V et al. Subthalamic stimulation in Parkinson disease: behavior and social adaptation. Arch Neurol 2006; 63: 1090-1095
  • 19 Seijo FJ, Alvarez-Vega MA, Gutierrez JC et al. Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson’s disease. Review of 272 procedures. Acta Neurochir 2007; 149: 867-875 discussion 876
  • 20 Bronstein JM, Tagliati M, Alterman RL et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 2011; 68: 165
  • 21 Okun MS, Fernandez HH, Wu SS et al. Cognition and mood in Parkinson’s disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 2009; 65: 586-595
  • 22 Saint-Cyr JA, Trepanier LL, Kumar R et al. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson’s disease. Brain 2000; 123 (10) 2091-2108
  • 23 Funkiewiez A, Ardouin C, Cools R et al. Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson’s disease. Mov Disord 2006; 21: 1656-1662
  • 24 Drapier D, Drapier S, Sauleau P et al. Does subthalamic nucleus stimulation induce apathy in Parkinson’s disease?. J Neurol 2006; 253: 1083-1091
  • 25 Castelli L, Lanotte M, Zibetti M et al. Apathy and verbal fluency in STN-stimulated PD patients. An observational follow-up study. J Neurol 2007; 254: 1238-1243
  • 26 Drapier D, Peron J, Leray E et al. Emotion recognition impairment and apathy after subthalamic nucleus stimulation in Parkinson’s disease have separate neural substrates. Neuropsychologia 2008; 46: 2796-2801
  • 27 Le JeuneF, Drapier D, Bourguignon A et al. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology 2009; 73: 1746-1751
  • 28 Porat O, Cohen OS, Schwartz R et al. Association of preoperative symptom profile with psychiatric symptoms following subthalamic nucleus stimulation in patients with Parkinson’s disease. J Neuropsychiatry Clin Neurosci 2009; 21: 398-405
  • 29 Denheyer M, Kiss ZH, Haffenden AM. Behavioral effects of subthalamic deep brain stimulation in Parkinson’s disease. Neuropsychologia 2009; 47: 3203-3209
  • 30 Kirsch-Darrow L, Zahodne LB, Marsiske M et al. The trajectory of apathy after deep brain stimulation: from pre-surgery to 6 months post-surgery in Parkinson’s disease. Parkinsonism Relat Disord 2011; 17: 182-188
  • 31 Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 2006; 16: 916-928
  • 32 Castelli L, Perozzo P, Zibetti M et al. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: effects on cognition, mood, anxiety and personality traits. Eur Neurol 2006; 55: 136-144
  • 33 Fields JA, Troster AI. Cognitive outcomes after deep brain stimulation for Parkinson’s disease: a review of initial studies and recommendations for future research. Brain Cogn 2000; 42: 268-293
  • 34 Le Jeune F, Peron J, Biseul I et al. Subthalamic nucleus stimulation affects orbitofrontal cortex in facial emotion recognition: a PET study. Brain 2008; 131: 1599-1608
  • 35 Temel Y, Tan S, Vlamings R et al. Cognitive and limbic effects of deep brain stimulation in preclinical studies. Front Biosci 2009; 14: 1891-1901
  • 36 Czernecki V, Pillon B, Houeto JL et al. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson’s disease?. J Neurol Neurosurg Psychiatry 2005; 76: 775-779
  • 37 Houeto JL, Mesnage V, Mallet L et al. Behavioural disorders, Parkinson’s disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002; 72: 701-707
  • 38 Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol 1998; 80: 1-27
  • 39 Wise RA. Roles for nigrostriatal – not just mesocorticolimbic – dopamine in reward and addiction. Trends Neurosci 2009; 32: 517-524
  • 40 Czernecki V, Schupbach M, Yaici S et al. Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom. Mov Disord 2008; 23: 964-969
  • 41 Voon V, Krack P, Lang AE et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson’s disease. Brain 2008; 131: 2720-2728
  • 42 Rodrigues AM, Rosas MJ, Gago MF et al. Suicide attempts after subthalamic nucleus stimulation for Parkinson’s disease. Eur Neurol 2010; 63: 176-179
  • 43 Soulas T, Gurruchaga JM, Palfi S et al. Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson’s disease. J Neurol Neurosurg Psychiatry 2008; 79: 952-954
  • 44 Myslobodsky M, Lalonde FM, Hicks L. Are patients with Parkinson’s disease suicidal?. J Geriatr Psychiatry Neurol 2001; 14: 120-124
  • 45 Juurlink DN, Herrmann N, Szalai JP et al. Medical illness and the risk of suicide in the elderly. Arch Intern Med 2004; 164: 1179-1184
  • 46 Schupbach M, Gargiulo M, Welter ML et al. Neurosurgery in Parkinson disease: a distressed mind in a repaired body?. Neurology 2006; 66: 1811-1816
  • 47 Frank MJ, Samanta J, Moustafa AA et al. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007; 318: 1309-1312
  • 48 Halbig TD, Tse W, Frisina PG et al. Subthalamic deep brain stimulation and impulse control in Parkinson’s disease. Eur J Neurol 2009; 16: 493-497
  • 49 York MK, Dulay M, Macias A et al. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson’s disease. J Neurol Neurosurg Psychiatry 2008; 79: 789-795
  • 50 Zibetti M, Pesare M, Cinquepalmi A et al. Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson’s disease. Parkinsonism Relat Disord 2009; 15: 128-133
  • 51 Ardouin C, Pillon B, Peiffer E et al. Bilateral subthalamic or pallidal stimulation for Parkinson’s disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 1999; 46: 217-223
  • 52 Volkmann J, Allert N, Voges J et al. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 2001; 56: 548-551
  • 53 Kalteis K, Standhardt H, Kryspin-Exner I et al. Influence of bilateral Stn-stimulation on psychiatric symptoms and psychosocial functioning in patients with Parkinson’s disease. J Neural Transm 2006; 113: 1191-1206
  • 54 Witt K, Daniels C, Reiff J et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurol 2008; 7: 605-614
  • 55 Follett KA, Weaver FM, Stern M et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med 2010; 362: 2077-2091
  • 56 Fassino S, Abbate Daga G, Gramaglia C et al. Novelty-seeking in Parkinson’s disease after deep brain stimulation of the subthalamic nucleus: a case-control study. Psychosomatics 2010; 51: 62-67
  • 57 Krack P, Kumar R, Ardouin C et al. Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord 2001; 16: 867-875
  • 58 Blomstedt P, Hariz MI. Are complications less common in deep brain stimulation than in ablative procedures for movement disorders?. Stereotact Funct Neurosurg 2006; 84: 72-81
  • 59 Raucher-Chene D, Charrel CL, de Maindreville AD et al. Manic episode with psychotic symptoms in a patient with Parkinson’s disease treated by subthalamic nucleus stimulation: improvement on switching the target. J Neurol Sci 2008; 273: 116-117
  • 60 Phares EJ. Introductions to personality. Glenview/IL: Scott, Foreman; 1988
  • 61 Witt K, Kuhn J, Timmermann L et al. Deep brain stimulation and the search for identity. NeuroEthics 2011; (in press)